budget

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:55 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Rare Artworks by Picasso and UAE Royal Family Member to be Auctioned together for the First Time

Source Node:
Time Stamp: February 9, 2023 5:01 AM - Modified On: February 9, 2023 - Published By:
Source Cluster:
Republished By Plato

The Rare Antiquities is Bridging The Gap Between Real World Art And Digital Art with this Auction on the 12th of February Highlights One of the paintings that will be featured in the auction was created by Artist Noora Alredhwan, the mother of Sheikh Humaid Bin Khalid Al Qasimi Three Picassos and a painting from the Royal Family of Ras Al Khaimah will be auctioned The UAE 50th Anniversary painting is on display for the first time since being showcased at the EXPO 2020 earlier last year The Rare Antiquities